Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 18.87% is 25% above its 5-year average of 15.06%, near the high end of its 5-year range (-100.39%–25.57%).
9.39% above its 12-month average of 17.25%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 25.57%.
NET PROFIT MARGIN
18.87%
NET PROFIT MARGIN AVG TTM
17.25%
NET PROFIT MARGIN AVG 3Y
15.34%
NET PROFIT MARGIN AVG 5Y
15.06%
NET PROFIT MARGIN AVG 10Y
16.83%
NET PROFIT MARGIN AVG 15Y
16.69%
NET PROFIT MARGIN AVG 20Y
16.80%
CURRENT VS TTM AVG
+9.39%
CURRENT VS 3Y AVG
+22.99%
CURRENT VS 5Y AVG
+25.32%
CURRENT VS 10Y AVG
+12.15%
CURRENT VS 15Y AVG
+13.03%
CURRENT VS 20Y AVG
+12.30%
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+105.00%
vs the sector median at left
Bristol-Myers Squibb Company
Market Cap
$129.92B
Net Profit Margin
18.87%
TTM Avg
17.25%
3Y Avg
15.34%
5Y Avg
15.06%
Market Cap
$130.27B
Net Profit Margin
34.89%
TTM Avg
13.94%
3Y Avg
25.44%
5Y Avg
29.40%
Market Cap
$135.05B
Net Profit Margin
28.45%
TTM Avg
28.09%
3Y Avg
25.67%
5Y Avg
26.14%
Market Cap
$118.53B
Net Profit Margin
13.93%
TTM Avg
13.55%
3Y Avg
12.62%
5Y Avg
13.06%
Market Cap
$146.59B
Net Profit Margin
15.95%
TTM Avg
15.52%
3Y Avg
19.51%
5Y Avg
19.37%
Market Cap
$109.17B
Net Profit Margin
14.43%
TTM Avg
13.09%
3Y Avg
13.60%
5Y Avg
12.87%
Market Cap
$103.88B
Net Profit Margin
1.12%
TTM Avg
1.05%
3Y Avg
1.09%
5Y Avg
0.48%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Company (BMY) | $129.92B | 18.87% | 17.25% | 15.34% | 15.06% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.27B | 34.89% | 13.94% | 25.44% | 29.40% |
| Intuitive Surgical, Inc. (ISRG)vs › | $135.05B | 28.45% | 28.09% | 25.67% | 26.14% |
| Medtronic plc (MDT)vs › | $118.53B | 13.93% | 13.55% | 12.62% | 13.06% |
| CVS Health Corp. (CVS)vs › | $117.03B | 1.18% | 0.84% | 1.34% | 1.79% |
| Danaher Corporation (DHR)vs › | $146.59B | 15.95% | 15.52% | 19.51% | 19.37% |
| Stryker Corporation (SYK)vs › | $109.17B | 14.43% | 13.09% | 13.60% | 12.87% |
| McKesson Corporation (MCK)vs › | $103.88B | 1.12% | 1.05% | 1.09% | 0.48% |
| Pfizer Inc. (PFE)vs › | $156.51B | 6.81% | 12.51% | 14.97% | 18.18% |
| Sanofi (SNY)vs › | $102.27B | 8.10% | 14.63% | 15.72% | 18.61% |
Operating Margin
28.3%
Net Profit Margin
18.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 25.57% |
| 2026-03-31 | 23.30% |
| 2025-12-31 | 8.69% |
| 2025-09-30 | 18.01% |
| 2025-06-30 | 10.68% |
| 2025-03-31 | 21.93% |
| 2024-12-31 | 0.58% |
| 2024-09-30 | 10.18% |
| 2024-06-30 | 13.77% |
| 2024-03-31 | -100.39% |
| 2023-12-31 | 15.35% |
| 2023-09-30 | 17.58% |
| 2023-06-30 | 18.47% |
| 2023-03-31 | 19.95% |
| 2022-12-31 | 17.73% |
| 2022-09-30 | 14.32% |
| 2022-06-30 | 11.95% |
| 2022-03-31 | 10.97% |
| 2021-12-31 | 19.79% |
| 2021-09-30 | 13.30% |
| 2021-06-30 | 9.01% |
| 2021-03-31 | 18.25% |
| 2020-12-31 | -90.59% |
| 2020-09-30 | 17.76% |
| 2020-06-30 | -0.84% |
| 2020-03-31 | -7.19% |
| 2019-12-31 | -13.29% |
| 2019-09-30 | 22.52% |
| 2019-06-30 | 22.83% |
| 2019-03-31 | 28.89% |
| 2018-12-31 | 19.42% |
| 2018-09-30 | 33.40% |
| 2018-06-30 | 6.54% |
| 2018-03-31 | 28.62% |
| 2017-12-31 | -42.72% |
| 2017-09-30 | 16.08% |
| 2017-06-30 | 17.81% |
| 2017-03-31 | 31.93% |
| 2016-12-31 | 17.05% |
| 2016-09-30 | 24.42% |
| 2016-06-30 | 23.94% |
| 2016-03-31 | 27.21% |
| 2015-12-31 | -4.60% |
| 2015-09-30 | 17.35% |
| 2015-06-30 | -3.12% |
| 2015-03-31 | 29.35% |
| 2014-12-31 | 0.31% |
| 2014-09-30 | 18.39% |
| 2014-06-30 | 8.56% |
| 2014-03-31 | 24.59% |
| 2013-12-31 | 16.35% |
| 2013-09-30 | 17.02% |
| 2013-06-30 | 13.24% |
| 2013-03-31 | 15.90% |
| 2012-12-31 | 22.07% |
| 2012-09-30 | -19.03% |
| 2012-06-30 | 14.52% |
| 2012-03-31 | 20.97% |
| 2011-12-31 | 15.62% |
| 2011-09-30 | 18.13% |
| 2011-06-30 | 16.60% |
| 2011-03-31 | 19.68% |
| 2010-12-31 | 9.45% |
| 2010-09-30 | 19.78% |
| 2010-06-30 | 19.44% |
| 2010-03-31 | 15.46% |
| 2009-12-31 | 274.64% |
| 2009-09-30 | 17.61% |
| 2009-06-30 | 18.26% |
| 2009-03-31 | 12.72% |
| 2008-12-31 | 23.70% |
| 2008-09-30 | 49.07% |
| 2008-06-30 | 14.68% |
| 2008-03-31 | 12.76% |
| 2007-12-31 | -1.82% |
| 2007-09-30 | 16.99% |
| 2007-06-30 | 14.33% |
| 2007-03-31 | 15.42% |
| 2006-12-31 | -3.18% |
| 2006-09-30 | 8.14% |
| 2006-06-30 | 13.69% |
| 2006-03-31 | 15.27% |
| 2005-12-31 | 9.94% |
| 2005-09-30 | 20.22% |
| 2005-06-30 | 20.54% |
| 2005-03-31 | 11.76% |
| 2004-12-31 | 4.16% |
| 2004-09-30 | 13.97% |
| 2004-06-30 | 9.71% |
| 2004-03-31 | 18.61% |
| 2003-12-31 | 10.06% |
| 2003-09-30 | 16.98% |
| 2003-06-30 | 17.85% |
| 2003-03-31 | 16.15% |
| 2002-12-31 | 7.80% |
| 2002-09-30 | 7.87% |
